Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients
Keywords:
Bordetella bronchiseptica, HIV, Pneumonia, Case reports [publication type], HumansAbstract
CONTEXT AND OBJECTIVE: Bordetella bronchiseptica (BB) is a Gram-negative coccobacillus responsible for respiratory diseases in dogs, cats and rabbits. Reports on its development in humans are rare. However, in immunosuppressed patients, especially in those with the immunodeficiency virus (HIV), BB can cause severe pulmonary infections. We report on two cases of pneumonia caused by BB in HIV-positive male patients in a university hospital. CASE REPORT: The first case comprised a 43-year-old patient who was admitted presenting chronic leg pain and coughing, with suspected pneumonia. BB was isolated from sputum culture and was successfully treated with trimethoprim/sulfamethoxazole in association with levofloxacin. The second case comprised a 49-year-old patient who was admitted presenting fever, nausea, sweating and a dry cough, also with suspected pneumonia. BB was isolated from sputum culture, tracheal secretions and bronchoalveolar lavage. The disease was treated with ciprofloxacin but the patient died. CONCLUSION: BB should be included in the etiology of pneumonia in immunodeficient HIV patients. As far as we know, these two were the first cases of pneumonia due to BB to occur in this university hospital
Downloads
References
Gueirard P, Weber C, Le Coustumier A, Guiso N. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol. 1995;33(8):2002-6.
Stevens-Krebbers AH, Schouten MA, Janssen J, Horrevorts AM. Nosocomial transmission of Bordetella bronchiseptica. J Hosp Infect. 1999;43(4):323-4.
Register KB, Sukumar N, Palavecino EL, Rubin BK, Deora R. Bordetella bronchiseptica in a pediatric cystic fibrosis patient: possible transmission from a household cat. Zoonoses Public Health. 2012;59(4):246-50.
Brady C, Ackerman P, Johnson M, McNamara J. Bordetella bronchiseptica in a pediatric Cystic Fibrosis center. J Cyst Fibros. 2014;13(1):43-8.
Yacoub AT, Katayama M, Tran J, et al. Bordetella bronchiseptica in the immunosuppressed population – a case series and review. Mediterr J Hematol Infect Dis. 2014;6(1):e2014031.
Echeverri-Toro L, Arango A, Ospina S, Agudelo C. Bacteriemia recurrente por Bordetella bronchiseptica en paciente con trasplante de medula ósea [Bordetella bronchiseptica recurrent bacteraemia in a patient with bone marrow transplantation]. Biomédica (Bogotá). 2015;35(3):302-5.
Won KB, Ha GY, Kim JS, et al. Relapsing peritonitis caused by Bordetella bronchiseptica in continuous ambulatory peritoneal dialysis patient: a case report. J Korean Med Sci. 2009;24 Suppl:S215-8.
Dlamini NR, Bhamjee A, Levick P, et al. Spontaneous bacterial peritonitis and pneumonia caused by Bordetella bronchiseptica. J Infect Dev Ctries. 2012;6(7):588-91.
Galeziok M, Roberts I, Passalacqua JA. Bordetella bronchiseptica pneumonia in a man with acquired immunodeficiency syndrome: a case report. J Med Case Rep. 2009;3:76.
Brooks GF, Carroll KC, Butel JS, et al. Microbiologia médica de Jawest, Melnick e Adelberg. 25th ed. Porto Alegre: AMGH; 2012.
Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev. 1991;4(3):243-55.
Mazumder SA, Cleveland KO. Bordetella bronchiseptica bacteremia in a patient with AIDS. South Med J. 2010;103(9):934-5.
Mesnard R, Guiso N, Michelet C, et al. Isolation of Bordetella bronchiseptica from a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1993;12(4):304-6.
García San Miguel L, Quereda C, Martínez M, et al. Bordetella bronchiseptica cavitary pneumonia in a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1998;17(9):675-6.
Dworkin MS, Sullivan PS, Buskin SE, et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin Infect Dis. 1999;28(5):1095-9.
Wernli D, Emonet S, Schrenzel J, Harbarth S. Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin Microbiol Infect. 2011;17(2):201-3.
García-de-la-Fuente C, Guzmán L, Cano ME, et al. Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica. Diagn Microbiol Infect Dis. 2015;82(1):20-5.
Engel C, Marinho M, Lima MR, et al. Infectologia. Rio de Janeiro: Medyklin; 2014.
Gill CJ, Sabin LL, Tham J, Hamer DH. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Bull World Health Organ. 2004;82(4):290-7.
Llombart M, Chiner E, Senent C. [Necrotizing pneumonia due to Bordetella bronchiseptica in an immunocompetent woman]. Arch Bronconeumol. 2006;42(5):255-6.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. M100-S25. 2015;35(3).
